SBIR/STTR Research Award
Molecular Analysis of Mycoplasma in AIDS
Award amount
$49,624Program and phase
SBIR · Phase IAward year
1993Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- STRATAGENE
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
The long-term objective is to develop primers for use in high stringency polymerase chain reaction (PCR) detection of mycoplasmas associated with human acquired immunodeficiency syndrome (AIDS). The primers will have commercial utility in analyzing the source, nature, and role of mycoplasma associated with the development of AIDS. In developing these primers, we will utilize a technological approach that could be used to derive PCR primers for other pathogens associated with opportunistic infections. In the first and second aims of this project, we will use two distinct, but complementary, technologies to develop mycoplasma-specific primers. In the first aim, we will utilize a variation of PCR, called intergeneic length polymorphism PCR (ILP-PCR), to obtain fingerprints of the t-RNA gene complex present in mycoplasma. In the second aim, we will initially use a PCR-based amplification system, coupled with restriction digestion, to obtain diagnostic restriction-length fragment polymorphisms (RFLPs); this procedure has been called mapped restriction endonuclease site polymorphisms (MRSP). The diagnostic PCR bands obtained in both methods will be sequenced in order to design highly specific PCR primers. In Phase II, we will use the specific primers on clinical samples from AIDS patients.
Technology keywords
Not reported